arrow
W

Wanda Christ

public health agency of sweden
H指数:18
被引数:1,100

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mpox-Specific Neutralizing Antibodies up to 9 Months Following 1 or 2 Doses of Intradermal MVA-BN Vaccination in Sweden

在瑞典,经皮内MVA-BN疫苗接种1或2剂后9个月内Mpox特异性中和抗体水平

2025-11-010
OAAI
LRP8 is a receptor for tick-borne encephalitis virus

LRP8是蜱传脑炎病毒的受体。

Nature
IF48.5
2025-09-240
PRE
SARS-CoV-2 and HSV-1 Induce Amyloid Aggregation in Human CSF Resulting in Drastic Soluble Protein Depletion

SARS-CoV-2和HSV-1诱导人CSF中的淀粉样蛋白聚集,导致可溶性蛋白急剧耗竭

2024-11-070
PRE
Discovery of a novel inhibitor of macropinocytosis with antiviral activity

发现具有抗病毒活性的新型巨胞饮抑制剂

2024-09-011
OAAI
Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19

严重新型冠状病毒肺炎中I型干扰素自身抗体与细胞免疫改变相关

2024-02-292
OAAI
Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19
2023-04-1517
OAAI
Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants

临床级ACE2作为阻断SARS-CoV-2变异的通用药物

2022-07-0435
OAAI
Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology
2022-03-146
OAAI
SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells
2022-03-0139
OAAI
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines

用ChAdOx1 nCoV-19和BNT162b2 mRNA疫苗进行同源或异源初次预防接种后,SARS-CoV-2免疫反应的持续时间长达六个月

2022-02-2412
OAAI
Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses

新型冠状病毒肺炎住院患者感染性SARS-CoV-2脱落与血清抗体反应的关系

2021-05-2715
OAAI